KKR KKR KKR

Press Release

KKR Completes Panasonic Healthcare Share Purchase
<< Back to Press Releases
Download PDF  

KKR Completes Panasonic Healthcare Share Purchase

March 31, 2014

TOKYO & NEW YORK–(BUSINESS WIRE)– Panasonic Corporation (“Panasonic”) and KKR, a leading global investment firm, today announced the completion of a share purchase agreement and a shareholders’ agreement under which Panasonic and KKR have become joint partners of Panasonic Healthcare Co., Ltd. (“Panasonic Healthcare”).

Panasonic and KKR will cooperate in supporting the growth of Panasonic Healthcare, leveraging their respective business resources, including their healthcare industry knowledge, technology, and specialist expertise, as well as KKR’s global healthcare industry investment experience and network. KKR and Panasonic now own 80% and 20%, respectively, of Panasonic Healthcare through Panasonic Healthcare Holdings Co., Ltd.

Panasonic President Kazuhiro Tsuga said, “We understand KKR has been actively investing in the expanding healthcare sector, and we highly respect KKR’s industry expertise and its capability to provide the necessary growth capital and operational know-how, in preparation for the future development of Panasonic Healthcare in the global healthcare industry.”

Commenting on the closing, KKR’s Co-Founder and Co-CEO Henry Kravis said, “We are pleased to have successfully completed this transaction and we look forward to working together with our new partners over the long term to support the realization of Panasonic Healthcare’s significant growth potential. Panasonic Healthcare is a world-class company and we intend to work together to make it an even better company. Japan is a very important and attractive market for KKR, and our experienced team on the ground in Japan will leverage KKR’s global expertise and experience to make this a highly successful partnership.”

Panasonic Healthcare President Kenji Yamane said, “Today marks the next stage in the growth and evolution of Panasonic Healthcare. KKR has built long-term relationships with its portfolio companies around the world, and I am delighted for their support as our new partner as we pursue growth in the medium and long term. We will be working closely with KKR in Japan and globally to accelerate growth by building out our global sales channels to major overseas healthcare facilities, and delivering high quality products and services to customers around the world.”

About Panasonic Corporation

Panasonic Corporation is a worldwide leader in the development and engineering of electronic technologies and solutions for customers in residential, non-residential, mobility and personal applications. Since its founding in 1918, the company has expanded globally and now operates over 500 consolidated companies worldwide, recording consolidated net sales of 7.30 trillion yen for the year ended March 31, 2013. Committed to pursuing new value through innovation across divisional lines, the company strives to create a better life and a better world for its customers. For more information about Panasonic, please visit the company’s website at http://panasonic.net/.

About Panasonic Healthcare

Established in 1969, Panasonic Healthcare is involved in developing, manufacturing, selling and servicing medical equipment. It seeks to strengthen its core businesses, In Vitro Diagnostics including self-monitoring of blood glucose systems, its Medicom businesses involved in medical IT businesses and its life sciences based Biomedical business and to continue to pursue an important role in the provision of optimal healthcare for all. For further information on Panasonic Healthcare please visit http://panasonic.net/corporate/segments/phc/.

About KKR

Founded in 1976 and led by Henry Kravis and George Roberts, KKR is a leading global investment firm with $94.3 billion in assets under management as of December 31, 2013. KKR manages assets through a variety of investment funds and accounts covering multiple asset classes.

With offices around the world, including seven across the Asia Pacific region, KKR seeks to create value by bringing operational expertise to its portfolio companies and through active oversight and monitoring of its investments. KKR complements its investment expertise and strengthens interactions with fund investors through its client relationships and capital markets platform. KKR & Co L.P. is publicly traded on the New York Stock Exchange (NYSE:KKR), and “KKR,” as used in this release, includes its subsidiaries, their managed investment funds and accounts, and/or their affiliated investment vehicles, as appropriate. For additional information, please visit www.kkr.com.

Panasonic / Panasonic Healthcare
Tokyo Public Relations Office
Tel: +81-3-3574-5664
Fax: +81-3-3574-5699
or
Panasonic News Bureau
Tel: +81-3-3542-6205
Fax: +81-3-3542-9018
or
KKR Asia Pacific
Steven Okun, +65-6922-5800
Steven.Okun@kkr.com
or
KKR Japan
Ashton Consulting
Tel: +81-3-5425-7220
KKRJapanPR@ashton.jp
or
KKR New York
Kristi Huller, +1-212-230-9722
Kristi.Huller@kkr.com

Source: KKR


<< Back to Press Releases

MEDIA CONTACTS

Americas

Kristi Huller
Miles Radcliffe-Trenner
Julia Kosygina
Telephone: +1 (212) 750-8300

Email: media@kkr.com

EMEA

Annabel Arthur
Telephone: +44 20 7839 9800

Email: kkrpr-uk@kkr.com

Asia-Pacific

Anita Davis
Wei Jun Ong
Telephone: +852 3602 7335

Email: media@kkr.com

Investor Relations

‍Craig Larson
Telephone: +1 (877) 610-4910
Outside US: +1 (212) 230-9410
Facsimile: +1 (212) 750-0003
Email: Investor-Relations@kkr.com

×

Listen to webcast

This presentation contains certain forward-looking statements pertaining to KKR & Co. Inc. and its consolidated subsidiaries (collectively “KKR”), including certain investment funds, vehicles and accounts that are managed by KKR (each, a “fund”). Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. The forward-looking statements are based on KKR’s beliefs, assumptions and expectations of its future performance, taking into account all information currently available to it. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to KKR or are within its control. If a change occurs, KKR’s business, financial condition, liquidity and results of operations, including but not limited to, assets under management, fee paying assets under management, after-tax distributable earnings, capital invested, syndicated capital, uncalled commitments, cash and short-term investments, fee related earnings, fee and yield segment EBITDA, core interest expense and book value, may vary materially from those expressed in the forward-looking statements. The following factors, among others, could cause actual results to vary from the forward-looking statements: whether KKR realizes all or any of the anticipated benefits from converting to a corporation and the timing of realizing such benefits; whether there are increased or unforeseen costs associated with the conversion, including any adverse change in tax law; the volatility of the capital markets; the general volatility of the capital markets; failure to realize the benefits of or changes in KKR’s business strategies including the ability to realize the anticipated synergies from acquisitions or strategic partnerships or other transactions; availability, terms and deployment of capital; availability of qualified personnel and expense of recruiting and retaining such personnel; changes in the asset management industry, interest rates or the general economy; underperformance of KKR's investments and decreased ability to raise funds; and the degree and nature of KKR’s competition. All forward-looking statements speak only as of the date they are made. KKR does not undertake any obligation to update any forward-looking statements to reflect circumstances or events that occur after the date on which such statements were made except as required by law. In addition, KKR’s business strategy is focused on the long-term and financial results are subject to significant volatility.

Additional information about factors affecting KKR, including a description of risks that may be important to a decision to purchase or sell any common or preferred stock of KKR & Co. Inc., can be found in KKR & Co. Inc.’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and its other filings with the SEC, which are available at www.sec.gov.

I understand  |   Go back
×

Listen to Presentation

Before viewing this presentation, please acknowledge your understanding that it has been prepared for KKR & Co. Inc. (NYSE:KKR) for the benefit of its public stockholders and is not intended to be a solicitation or sale of any of the securities, funds or services that it may discuss. Please click on "I understand" to view the presentation.

I understand  |   Go back